That is necessary, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (brownstone research stock). And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a development almost no one discovered. But it's going to have extensive ramifications for treating disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment opportunities in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (future report). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly before going greater - jeff brown top biotech stock 2021. I have actually been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mostly educating readers. However that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so many great personal companies on the verge of striking the general public markets And I've been dealing with a new method for you to invest even before these business go public.
This chance has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our normal beat (jeff brown stock predictions). And when it pertains to tech investing, we leave it to the experts. The good news is, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we understand (biotech stock). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid growth and producing unbelievable chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. future report. But in spite of what lots of readers might think, this is a pattern that's simply getting going. Although the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (exponential growth). Losing two months of manufacturing and sales really affects the number of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More notably, the delays brought on by the pandemic created a lots of suppressed need. Which demand is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be delivered in 2021 - exponential growth. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I have actually explained its 3 different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase 3, 5G services begin to be provided (second wave). That's when we begin to see applications operating on 5G networks. Consider things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer. This starts something of a virtuous cycle: Many people don't really care about the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities going forward will be massive. Stepping away from 5G, the next essential technology I visualize in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well comprehended. And throughout that time, there were truly just three business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is efficiently a greenfield chance.
There's room for numerous business to exist in this space. black sea. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is essential since the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however numerous drug treatments produced utilizing this technology. This was one of those developments that nearly no one observed. However it's going to have extensive ramifications for curing disease. And, obviously, there will be plenty of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe considerably prior to going higher. I have actually been covering bitcoin for a very long time now. Among the very first research study reports I ever released was on bitcoin - jeff brown 1 biotech company. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. democratic republic. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, but we might not independently validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the marketplace. He's always on the hunt for brand-new chances, and he shares much of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively anticipated a few of the biggest financial events of the previous 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, but Jeff Brown's precise predictions have actually made him legions of dedicated followers. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study uses a number of research services with a wide range of specializations - united states.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown stock predictions. On its website, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the finest financial investment research study has not been available to private investors. It has actually been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown genetic sequencing stock. The objective of Brownstone Research study is to make that sort of proprietary research offered to any financiers wanting to gain an edge in the markets. The goal is simple to deliver unique and successful financial investment research study discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you understand even a little bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. biotech stock. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown believes S.A.V. jeff brown predictions 2021. could be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two cutting-edge innovations: expert system and electrical cars. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile industry's Holy Grail. As you understand, electrical lorries and self-driving cars and truck stocks have actually been big this year, but the Wall Street maker has actually approved buzz without much concrete outcome. Regardless of an extreme increase in competition over the previous few years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech might be the magic string that connects it all together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transportation. Basically, this innovation would permit you to rent your cars and truck as a self-governing, self-driving taxi when you're not using it. You simply leave the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a hefty portion of the profits. It sounds insane, however it might be closed than you think.